Category: Steris Corp.
Here's a look at some of the top regulatory stories for medical device companies this week: Medtronic announces leadership roster for post-Covidien merger; Allergan raises outlook; says Valeant offer undervalues company; EuroZone anti-trust regulators to rule next month on $43B Covidien buy; Steris to buy UK's Synergy Health, tax savings eyed; Bioventus bolsters bone healing lineup
Steris agrees to a $1.9 billion buyout of U.K. sterilization services provider Synergy Health in the 1st inversion deal since a U.S. Treasury crackdown.
Here's a look at some of the top legal news stories for medical device companies this week: Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Medtronic fights tax dodging rhetoric in Covidien merger; Travelers holds out on BD's $67M coverage claim; Abbott CEO defends inversions amid corporate exodus furor; Steris, Medtrica win legal fees in Cygnus Medical patent spat;
A federal judge agrees to award legal fees to Steris and Medtrica in their patent infringement win over Cygnus Medical, after a U.S. Supreme court decision reboots the rules on awarding legal costs.
FDA inspectors identify a handful of violations at Steris Isomedix's sterilization facility, including concerns that the company failed to respond appropriately to incidents in which employees were manipulating data.
Steris's (NYSE:STE) Isomedix division is in the FDA's hotseat after inspectors turned up incidents in which employees faked data on testing for medical devices.
Steris puts a ribbon on the $165 million acquisition of Integrated Medical Systems and reports its Q4 earnings, tallying a $20.5 million restructuring charge tied to the closure of its Hopkins, Ohio, manufacturing facility and the termination of 150 workers.
Ohio infection control solutions provider Steris (NYSE:STE) closed the previously reported acquisition of Integrated Medical Systems, paying about $165 million for the surgical instrument management company.
Steris expands its specialty services business with the $165 million acquisition of Integrated Medical Systems and its surgical instrument repair, management and processing services.
Steris (NYSE:STE) announced this week plans to acquire Integrated Medical Systems in a deal worth up to $175 million. Steris will pay $165 million to acquire the instrument services company, plus another $10 million for real estate, according to a press release.